Lanraplenib succinate inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans. Lanraplenib succinate is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in deve
Molecular Weight:
1241.294
CAS Number:
[1800047-00-0]
Formula:
C58H68N18O14
Target:
Syk
* VAT and and shipping costs not included. Errors and price changes excepted